TG THERAPEUTICS, INC. Debt Conversion, Converted Instrument, Amount
TG THERAPEUTICS, INC. (TGTX) reported Debt Conversion, Converted Instrument, Amount of $595.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2024-02-29
- TG THERAPEUTICS, INC. debt conversion, converted instrument, amount for the quarter ending 2023-03-31 was $595.00K.
- TG THERAPEUTICS, INC. debt conversion, converted instrument, amount for the quarter ending 2019-03-31 was $993.00K.
- TG THERAPEUTICS, INC. debt conversion, converted instrument, amount for fiscal 2023 was $595.00K.
- TG THERAPEUTICS, INC. debt conversion, converted instrument, amount for fiscal 2021 was $2.19M.
- TG THERAPEUTICS, INC. debt conversion, converted instrument, amount for fiscal 2019 was $993.00K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|
| 2023-12-31 | $595.00K 10-K · filed 2024-02-29 | |
| 2023-03-31 | $595.00K 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $2.19M 10-K · filed 2023-03-01 | |
| 2019-12-31 | $993.00K 10-K · filed 2022-03-01 | |
| 2019-03-31 | $993.00K 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |